Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Maintains Buy on Masimo, Raises Price Target to $192

Needham analyst Mike Matson maintains Masimo (NASDAQ:MASI) with a Buy and raises the price target from $173 to $192.
byBenzinga Newsdesk
March 1, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Needham analyst Mike Matson maintains Masimo (NASDAQ:MASI) with a Buy and raises the price target from $173 to $192.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

GH Research Psychedelics Firm Q2 2023 Repots $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026

By Lara Goldstein
August 24, 3:03 PM
GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharma company developing novel mebufotenin (5-MeO-DMT) therapies for Treatment-Resistant Depression (TRD) and one of the highest trading psychedelics stocks listed in Nasdaq, shared its financial results and business updates for its second quarter en

GHRS